Skip to main content
SpringerLink
Log in

Progress in multiple sclerosis research in the last year

  • Medical Progress in the Journal of Neurology
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Herein, we summarize the main articles describing novel findings in multiple sclerosis published in the Journal of Neurology over the last year, including clinical, therapeutic and research issues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363:978–988

    Article  PubMed  Google Scholar 

  2. Yaldizli Ö, Glassl S, Sturm D, Papadopoulou A, Gass A, Tettenborn B, Putzki N (2011) Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J Neurol 258:2199–2205

    Article  PubMed  Google Scholar 

  3. Morgante F, Dattola V, Crupi D, Russo M, Rizzo V, Ghilardi MF et al (2012) Is central fatigue in multiple sclerosis a disorder of movement preparation? J Neurol 258:263–272

    Article  Google Scholar 

  4. Horowski S, Zettl UK, Benecke R, Walter U (2012) Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis. J Neurol 258:195–202

    Article  Google Scholar 

  5. Judica E, Martinelli Boneschi F, Ungaro D, Comola M, Gatti R, Comi G, Rossi P (2012) Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis. J Neurol 258:835–839

    Article  Google Scholar 

  6. Sacco R, Bussman R, Oesch P, Kesselring J, Beer S (2012) Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial. J Neurol 258:889–894

    Article  Google Scholar 

  7. Mori F, Ljoka C, Magni E, Codecà C, Kusayanagi H, Monteleone F et al (2011) Transcranial magnetic stimulation primes the effect of exercise therapy in multiple sclerosis. J Neurol 258:1281–1287

    Article  PubMed  Google Scholar 

  8. McNicholas N, Chataway J (2011) Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination. J Neurol 258:1545–1547

    Article  PubMed  Google Scholar 

  9. Wipfler P, Pilz G, Broussalis E, Golaszewski SM, Kunz A, Trinka E, Kraus J (2011) Acute pulmonary edema caused by a multiple sclerosis relapse. J Neurol 258:1176–1179

    Article  PubMed  CAS  Google Scholar 

  10. Valentino P, Nisticò R, Pirritano D, Bilotti G, Del Giudice F, Sturniolo M, Quattrone A (2011) Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report. J Neurol 258:1349–1350

    Article  PubMed  CAS  Google Scholar 

  11. Nociti V, Batocchi AP, Luigetti M, Conte A, Lorusso VS, Roiati S et al (2011) Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else? J Neurol 258:1965–1970

    Article  PubMed  Google Scholar 

  12. Häne A, Bargetzi M, Hewer E, Bruehlmeier M, Khamis A, Roelcke U (2011) Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumor. J Neurol 258:318–320

    Article  PubMed  Google Scholar 

  13. Morrow SA, Jurgensen S, Forrestal F, Munchauer FE, Benedict RHB (2012) Effects of acute relapses on neuropsychological status in multiple sclerosis patients. J Neurol 258:1603–1608

    Article  Google Scholar 

  14. Nocentini U, Pasqualetti P, Bonavita S, Buccafusca M, De Caro MF, Farina D et al (2006) Cognitive dysfunctions in patients with relapsing-remitting multiple sclerosis. Mult Scler 12:77–87

    Article  PubMed  CAS  Google Scholar 

  15. Akbar N, Honarmand K, Kou N, Feinstein A (2011) Validity of a computerized version of the Symbol Digit Modalities Test in multiple sclerosis. J Neurol 258:373–379

    Article  PubMed  Google Scholar 

  16. Honarmand K, Akbar N, Kou N, Feinstein A (2011) Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite. J Neurol 258:244–249

    Article  PubMed  Google Scholar 

  17. Zaaraoui W, Reuter F, Rico A, Faivre A, Crespy L, Malikova I et al (2011) Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration. J Neurol 258:811–819

    Article  PubMed  Google Scholar 

  18. Reis A, Mateus C, Macário MC, Faria de Abreu JR, Castelo-Branco M (2011) Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis. J Neurol 258:1695–1704

    Article  PubMed  Google Scholar 

  19. Healy B, Chitnis T, Engler D (2011) Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies. J Neurol 258:1812–1819

    Article  PubMed  Google Scholar 

  20. Invernizzi P, Bertolasi L, Bianchi MR, Turatti M, Gajofatto A, Benedetti MD (2011) Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. J Neurol 258:1933–1939

    Article  PubMed  Google Scholar 

  21. Jozefowicz-Korczynska M, Pajor AM (2011) Evaluation of the smooth pursuit tests in multiple sclerosis patients. J Neurol 258:1795–1800

    Article  PubMed  Google Scholar 

  22. Prochnow D, Donell J, Schäfer R, Jörgens S, Hartung HP, Franz M, Seitz RJ (2011) Alexithymia and impaired facial affect recognition in multiple sclerosis. J Neurol 258:1683–1688

    Article  PubMed  CAS  Google Scholar 

  23. Argyriou AA, Iconomou G, Ifanti AA, Karanasios P, Assimakopoulos K, Makridou A et al (2011) Religiosity and its relation to quality of life in primary caregivers of patients with multiple sclerosis: a case study in Greece. J Neurol 258:1114–1119

    Article  PubMed  Google Scholar 

  24. Malucchi S, Gilli F, Caldano M, Sala A, Capobianco M, di Sapio A et al (2011) One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. J Neurol 258:895–903

    Article  PubMed  CAS  Google Scholar 

  25. Menge T, Hartung HP, Kieseier BC (2011) Neutralizing antibodies in interferon beta treated patients with multiple sclerosis: knowing what to do now. J Neurol 258:904–907

    Article  PubMed  Google Scholar 

  26. Zwibel H, Pardo G, Smith S, Denney D, Oleen-Burkey M (2011) A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis. J Neurol 258:402–411

    Article  PubMed  CAS  Google Scholar 

  27. Hellwig K, Gold R (2011) Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis. J Neurol 258:502–503

    Article  PubMed  Google Scholar 

  28. Lebrun C, Vermersch P, Brassat D, Defer G, Rumbach L, Clavelou P et al (2011) Cancer and multiple sclerosis in the era of disease-modifying treatments. J Neurol 258:1304–1311

    Article  PubMed  Google Scholar 

  29. Havla J, Gerdes LA, Meinl I, Krumbholz M, Faber H, Weber F, Pellkofer HL et al (2011) De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. J Neurol 258:1665–1669

    Article  PubMed  CAS  Google Scholar 

  30. Magraner MJ, Coret F, Navarré A, Boscá I, SimóM Escutia M et al (2011) Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study. J Neurol 258:1805–1811

    Article  PubMed  Google Scholar 

  31. MacManus DG, Miller DH, Kappos L, Gold R, Havrdova E, Limmroth V et al (2011) BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. J Neurol 258:449–456

    Article  PubMed  CAS  Google Scholar 

  32. Duddy M, Haghikia A, Cocco E, Eggers C, Drulovic J, Carmona O et al (2011) Managing MS in a changing treatment landscape. J Neurol 258:728–739

    Article  PubMed  Google Scholar 

  33. Fjeldstad AS, McDaniel J, Witman MAH, Ives SJ, Zhao J, Rose JW et al (2011) Vascular function and multiple sclerosis. J Neurol 258:2036–2042

    Article  PubMed  CAS  Google Scholar 

  34. Steffensen LH, Jørgensen L, Straume B, Ivar Mellgren S, Kampman MT (2011) Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol 258:1624–1631

    Article  PubMed  CAS  Google Scholar 

  35. Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, Ascherio A (2011) Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol 258:479–485

    Article  PubMed  CAS  Google Scholar 

  36. Simon KC, Munger KL, Kraft P, Hunter DJ, De Jager PL, Ascherio A (2011) Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Neurol 258:1676–1682

    Article  PubMed  CAS  Google Scholar 

  37. Koutsis G, Karadima G, Floroskufi P, Sfagos C, Vassilopoulos D, Panas M (2011) The rs10492972 KIF1B polymorphism and disease progression in Greek patients with multiple sclerosis. J Neurol 258:1726–1728

    Article  PubMed  Google Scholar 

  38. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, Hillert J et al (2008) Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 40:1402–1403

    Article  PubMed  CAS  Google Scholar 

  39. Edwards LJ, Sharrack B, Ismail A, Tumani H, Constantinesku CS (2011) Central inflammation versus peripheral regulation in multiple sclerosis. J Neurol 258:1518–1527

    Article  PubMed  CAS  Google Scholar 

  40. Axelsson M, Malmeström C, Nilsson S, Haghighi S, Rosengren L, Lycke J (2011) Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol 258:882–888

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. “Dino Ferrari” Center, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122, Milan, Italy

    Daniela Galimberti & Elio Scarpini

Authors
  1. Daniela Galimberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elio Scarpini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniela Galimberti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galimberti, D., Scarpini, E. Progress in multiple sclerosis research in the last year. J Neurol 259, 1497–1501 (2012). https://doi.org/10.1007/s00415-012-6578-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-012-6578-3

Keywords

Search

Navigation